QA: Alzamend Neuro Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001677077_2022_Alzamend_Neuro_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001677077')"}

Graph

Absolute values for 0001677077, Alzamend Neuro Inc.

  xvar xval
0 AssetsCurrent 2,912,590
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 899,643
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,641,172
9 ResearchAndDevelopmentExpense 1,310,716
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -94,679
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,912,590
1 Liabilities 899,643
2 Expenses 4,951,888
3 Revenues 0
4 StockholdersEquity 2,012,947
5 NetIncome -5,046,567
6 ComprehensiveNetIncome -5,046,567
7 BaseVar 4,429,400
8 EconomicCapitalRatio -0.831

Edgar->Model Mapping

Feature Distribution

Change over Time